GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Stock Based Compensation

Curatis Holding AG (XSWX:CURN) Stock Based Compensation : CHF0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Stock Based Compensation?

Curatis Holding AG's Stock Based Compensation for the six months ended in Jun. 2024 was CHF0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2024 was CHF0.00 Mil.


Curatis Holding AG Stock Based Compensation Historical Data

The historical data trend for Curatis Holding AG's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Stock Based Compensation Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Stock Based Compensation
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Stock Based Compensation Get a 7-Day Free Trial - - - - -

Curatis Holding AG Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.00 Mil.


Curatis Holding AG Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.